Xeris Biopharma Holdings
XERS
XERS
49 hedge funds and large institutions have $161M invested in Xeris Biopharma Holdings in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $184M → $161M (-$22.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.5M | |
| 2 | +$8.13M | |
| 3 | +$7.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.85M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$5.9M |
Top Sellers
| 1 | -$3.45M | |
| 2 | -$1.44M | |
| 3 | -$1.4M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2K |